Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study

Photodiagnosis and Photodynamic Therapy

Volumn 12, Issue 2, 2015, Pages 193-200

  Inoue, Keiji ^a   Anai, Satoshi ^b   Fujimoto, Kiyohide ^b   Hirao, Yoshihiko ^b   Furuse, Hiroshi ^c   Kai, Fumitake ^c   Ozono, Seiichiro ^c   Hara, Takahiko ^d   Matsuyama, Hideyasu ^d   Oyama, Masafumi ^e   Ueno, Munehisa ^e   Fukuhara, Hideo ^a   Narukawa, Mamoru ^f   Shuin, Taro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Yamaguchi University Graduate School of Medicine   (Japan)

^e SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^f KITASATO UNIVERSITY   (Japan)

Author keywords

5 Aminolevulinic acid; Non muscle invasive bladder cancer; Oral administration; Photodynamic diagnosis; Randomized clinical trial

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOLEVULINIC ACID; AMYLASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; 5-AMINOLEVULINIC ACID HEXYL ESTER; PHOTOSENSITIZING AGENT;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATRIAL FIBRILLATION; BLADDER DISEASE; BLADDER TAMPONADE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE CYSTOSCOPY; HEART FAILURE; HEMATURIA; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NON MUSCLE INVASIVE BLADDER CANCER; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHOTODYNAMICS; PHOTOSENSITIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR; WHITE LIGHT ENDOSCOPY; ADULT; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DOSE RESPONSE; FLUORESCENCE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROCEDURES; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CYSTOSCOPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 84930476621     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2015.03.008     Document Type: Article

References (20)

1. Chopin D.K., Gattegno B. Superficial bladder tumors. Eur Urol 2002, 42:533-541.
2. Sylvester R.J., van der Meijden A.P., Oosterlinck W., Witjes J.A., Bouffioux C., Denis L., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006, 49:466-477.
3. Malik Z., Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer 1987, 56:589-595.
4. Iinuma S., Farshi S.S., Ortel B., Hasan T. A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br J Cancer 1994, 70:21-28.
5. Steinbach P., Weingandt H., Baumgartner R., Kriegmair M., Hofstadter F., Knuchel R. Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid. Photochem. Photobiol. 1995, 62:887-895.
6. Kriegmair M., Baumgartner R., Knuechel R., Steinbach P., Ehsan A., Lumper W., et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994, 44:836-841.
7. Filbeck T., Pichlmeier U., Knuechel R., Wieland W.F., Roessler W. Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma. Urology 2002, 60:1025-1028.
8. Hungerhuber E., Stepp H., Kriegmair M., Stief C., Hofstetter A., Hartmann A., et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007, 69:260-264.
9. Denzinger S., Burger M., Walter B., Knuechel R., Roessler W., Wieland W.F., et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007, 69:675-679.
10. Inoue K., Fukuhara H., Shimamoto T., Kamada M., Iiyama T., Miyamura M., et al. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for non-muscle invasive bladder cancer. Cancer 2012, 118:1062-1074.
11. Babjuk M., Burger M., Zigeuner R., Shariat S.F., van Rhijn B.W., Compérat E., et al. European Association of Urology (EAU) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013, 64:639-653.
12. Hall M.C., Chang S.S., Dalbagni G., Pruthi R.S., Seigne J.D., Skinner E.C., et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007, 178:2314-2330.
13. Burger M., Stief C.G., Zaak D., Stenzl A., Wieland W.F., Jocham D., et al. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors. Urology 2009, 74:1282-1286.
14. Kausch I., Sommerauer M., Montorsi F., Stenzl A., Jacqmin D., Jichlinski P., et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol 2010, 57:595-606.
15. Mowatt G., N'Dow J., Vale L., Nabi G., Boachie C., Cook J.A., et al. Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int J Technol Assess Health Care 2011, 27:3-10. Aberdeen Technology Assessment Review (TAR) Group.
16. Shen P., Yang J., Wei W., Li Y., Li D., Zeng H., et al. Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. BJU Int 2012, 110:E209-E215.
17. Rink M., Babjuk M., Catto J.W., Jichlinski P., Shariat S.F., Stenzl A., et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol 2013, 64:624-638.
18. Burger M., Grossman H.B., Droller M., Schmidbauer J., Hermann G., Drăgoescu O., et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol 2013, 64:846-854.
19. Navone N.M., Polo C.F., Frisardi A.L., Andrade N.E., Battle A.M. Heme biosynthesis in human breast cancer - mimetic in vitro studies and some heme enzymic activity levels. Int J Biochem 1990, 22:1407-1411.
20. Fukuda H., Paredes S., Batlle A.M. Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Comp Biochem Physiol B 1992, 102:433-436.